Milestone Pharmaceuticals (MIST) Assets Average (2019 - 2026)

Milestone Pharmaceuticals' Assets Average history runs 8 years deep, the most recent figure standing at $153.6 million for Q1 2026.

• Quarterly Assets Average rose 123.68% year-over-year to $153.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153.6 million (up 123.68% YoY) and the FY2025 annual result came in at $94.5 million, up 25.43% from the prior year.
• Assets Average was $153.6 million for Q1 2026 at Milestone Pharmaceuticals, up from $100.7 million in the prior quarter.
• Across five years, Assets Average topped out at $153.6 million in Q1 2026 and bottomed at $54.7 million in Q2 2025.
• A 5-year average of $90.5 million and a median of $88.5 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2025 — Assets Average slumped 40.99% — and 2026, when it jumped 123.68%.
• Milestone Pharmaceuticals' Assets Average stood at $80.1 million in 2022, then rose by 1.3% to $81.2 million in 2023, then fell by 2.55% to $79.1 million in 2024, then gained by 27.25% to $100.7 million in 2025, then jumped by 52.65% to $153.6 million in 2026.
• Business Quant data shows MIST's Assets Average at $153.6 million in Q1 2026, $100.7 million in Q4 2025, and $67.6 million in Q3 2025.